Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s13300-016-0211-x
Published Online: 2016-11-11
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anderson, John E.
Wright, Eugene E. Jr.
Shaefer, Charles F. Jr.
Text and Data Mining valid from 2016-11-11
Article History
Received: 12 September 2016
First Online: 11 November 2016